Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New insights into retention of FMDV
The outcomes of the study could benefit farmers of African buffalo, whose herds can harbour the disease for five years or more.
Foot-and-Mouth Disease study explores persistent infection.

A new study has revealed detailed insights into how the Foot-and-Mouth Disease Virus (FMDV) causes persistent infection in livestock.

A team comprised of researchers from the Roslin Institute and the Pirbright Institute explored how FMDV interacts with immune cells, in order to inform the development of a future long-lasting vaccine.

Using mice in the study, the scientists found that FMDV binds to follicular dendritic cells, found in lymphoid tissues in the immune system, such as in the spleen.

The Pirbright Institute's Professor Bryan Charleston explained: “This research helps to bridge the knowledge gap of how the immune system deals with FMDV infection in large animals.

“Our extensive work in African buffalo, a natural host of the disease, allowed us to predict why and how persistence may occur and then test this theory in a small animal model.”

Follicular dendritic cells, which FMDV binds to, behave similarly to spider webs, trapping foreign particles and certain viruses within them for significant periods of time, in order for the other cells in the immune system to make immune responses.

This retention of the virus within the follicular dendritic cells is what the researchers believe may assist the virus in persisting in livestock, allowing them to become carriers and risking the health of other susceptible livestock.

Professor Neil Mabbott, of the Roslin Institute, commented on the value of the research for informing future vaccine development: “Our research has uncovered a key biological process by which the virus for Foot-and-Mouth Disease is able to remain in the immune systems of animals such as African buffalo.

“This could inform efforts to develop improved vaccines which, unlike current vaccines, provide longer term protection to safeguard livestock.”

The study is published in PLOS Pathogens.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.